Trust Size
$4M
Peak Price
$25600.00
Current Price
$0.04
Return
-99.6%
Price Journey
What Happened
CERo Therapeutics (now Cerevel Therapeutics Holdings) is a biotechnology company focused on developing engineered T-cell therapies for cancer using its proprietary CER-T platform.
CERo Therapeutics went public through a SPAC merger and is developing cancer immunotherapies that use chimeric engulfment receptors rather than traditional CAR-T approaches. The stock has collapsed to pennies, and the company faces significant challenges in advancing its early-stage pipeline with limited financial resources.
Timeline
2021-09-28
S-1 Registration Filed
2024-01-22
Merger Proxy Filed (DEFM14A)
🔀 Reverse Stock Split
Reverse split ratio: . Reverse splits are used to avoid delisting but destroy shareholder value through the illusion of a higher stock price.
SEC Filing Details
CIK Number
1870404
Total SEC Filings
419
State of Incorporation
DE
Last Filing Date
2026-03-12
Business Location
Philadelphia, PA
Trust/Asset Size
$4M
Data sourced from SEC EDGAR Company Facts API and EFTS search index.
📄 SEC Filings
View all EDGAR filings for Cero Therapeutics Holdings